Jacobs Levy Equity Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$459K Buy
+40,506
New +$397K ﹤0.01% 836
2024
Q4
Sell
-823,428
Closed -$2.59M 955
2024
Q3
$2.59M Buy
+823,428
New +$2.42M 0.01% 553
2023
Q4
Sell
-257,411
Closed -$5.24M 997
2023
Q3
$5.24M Sell
257,411
-335,378
-57% -$8.43M 0.03% 371
2023
Q2
$17.3M Sell
592,789
-143,363
-19% -$3.93M 0.1% 212
2023
Q1
$20.7M Buy
736,152
+9,516
+1% +$244K 0.13% 182
2022
Q4
$13.5M Buy
726,636
+233,323
+47% +$4M 0.09% 240
2022
Q3
$7.77M Buy
493,313
+311,055
+171% +$6.99M 0.06% 306
2022
Q2
$4.6M Buy
+182,258
New +$5.45M 0.04% 430
2020
Q3
Sell
-49,884
Closed -$2.04M 1042
2020
Q2
$2.04M Buy
49,884
+35,161
+239% +$1.01M 0.02% 530
2020
Q1
$227K Buy
+14,723
New +$309K ﹤0.01% 859

Other funds holding CRNC

Jacobs Levy Equity Management's CRNC Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Cerence (CRNC) in Q2 2026: 40,506 shares worth $459K. The stake represents ﹤0.01% of the portfolio and ranks #836 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in CRNC as recently as Q3 2024.

Jacobs Levy Equity Management first reported a position in CRNC in Q1 2020 and has held it in 10 quarters since. The position peaked at $20.7M in Q1 2023. 195 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Jacobs Levy Equity Management held 40,506 shares of Cerence worth $459K as of Q2 2026.
  • Cerence was a new Jacobs Levy Equity Management position in Q2 2026.
  • Cerence made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #836 holding.
  • Jacobs Levy Equity Management first reported a position in Cerence in Q1 2020 and has held it in 10 quarters since.
  • Jacobs Levy Equity Management's Cerence position peaked at $20.7M in Q1 2023.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.